← Back to Search

TELL Tool Intervention for Infertility

N/A

Waitlist Available

Led By Patricia Hershberger, PhD

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 15

Awards & highlights

Study Summary

This trialwill study the feasibility of a digital tool to help donor-recipient parents inform their children about their donor conception, and an eBook on parenting as a control.

Eligible Conditions

Infertility
Disclosure
Parenting

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 15

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 15

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 15 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Participants Who Disclosed the Donor Conception to Their Children

Secondary outcome measures

Change in Disclosure Anxiety

Change in Disclosure Competence

Change in Disclosure Intention

Other outcome measures

Acceptability of the TELL Tool and eBook

Acceptability of the TELL Tool, eBook and Study Protocol

Pretesting of the Measures

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TELL Tool GroupExperimental Treatment1 Intervention

Parents in the TELL Tool group will complete a decision support aid that has four interactive, multimedia and multicomponent modules that will be administered digitally. It will take parents about 60 minutes to complete the TELL Tool.

Group II: eBook Attention-ControlActive Control1 Intervention

Parents in the eBook attention-control group will complete one interactive, multimedia and multicomponent program that contains information about good parenting principles and is administered digitally. It will take parents about 60 minutes to complete the eBook attention control.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

TELL Tool Intervention

2021

N/A

~80

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of Nursing Research (NINR)NIH

579 Previous Clinical Trials

10,376,307 Total Patients Enrolled

University of Illinois at ChicagoLead Sponsor

607 Previous Clinical Trials

1,559,280 Total Patients Enrolled

4 Trials studying Infertility

427 Patients Enrolled for Infertility

Patricia Hershberger, PhDPrincipal Investigator - University of Illinois Chicago

University of Illinois at Chicago

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment of this experimental research?

"Affirmative, the data posted on clinicaltrials.gov confirms that this medical experiment is currently recruiting volunteers and was initially published April 12th of 2021. The study requires 60 participants from a single site, with its most recent update taking place October 28th 2022."

Answered by AI

Are qualified individuals being admitted to participate in the trial at this time?

"Clinicaltrials.gov indicates that this clinical trial is in its active recruitment phase, with the original posting occurring on April 12th 2021 and an updated entry posted October 28th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility Trial of the TELL Tool Intervention

Patricia Hershberger, PhD, RN, FNP-BC, FAAN 2021. "Feasibility Trial of the TELL Tool Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04841967.